| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0022-1759(88)90127-5 |
| P698 | PubMed publication ID | 3397545 |
| P2093 | author name string | J Hermon-Taylor | |
| A Cook | |||
| A Jehanli | |||
| B M Austen | |||
| P R Hurley | |||
| P433 | issue | 2 | |
| P304 | page(s) | 195-203 | |
| P577 | publication date | 1988-07-01 | |
| P1433 | published in | Journal of Immunological Methods | Q15755939 |
| P1476 | title | Development of radioimmunoassays for free tetra-L-aspartyl-L-lysine trypsinogen activation peptides (TAP) | |
| P478 | volume | 111 |
| Q70635890 | Absence of trypsinogen autoactivation and immunolocalization of pancreatic secretory trypsin inhibitor in acinar cells in vitro |
| Q73270884 | Benefits of various dextrans after delayed therapy in necrotizing pancreatitis of the rat |
| Q44021887 | Characterization of the glutamine synthetase amplifiable eukaryotic expression system applied to an integral membrane protein—The human thyrotropin receptor |
| Q71811719 | Cholecystokinin-8 induces edematous pancreatitis in dogs associated with short burst of trypsinogen activation |
| Q67833559 | Development of enzyme-linked immunosorbent assay for free human pro-colipase activation peptide (APGPR) |
| Q72992165 | Differing roles of nitric oxide in the pathogenesis of acute edematous versus necrotizing pancreatitis |
| Q42258748 | Dopamine in models of alcoholic acute pancreatitis |
| Q73906897 | Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study |
| Q41672234 | Effect of microcirculatory perfusion on distribution of trypsinogen activation peptides in acute experimental pancreatitis |
| Q35841080 | Elevated calcium and activation of trypsinogen in rat pancreatic acini |
| Q52991908 | Endothelin receptor blockade improves fluid sequestration, pancreatic capillary blood flow, and survival in severe experimental pancreatitis. |
| Q44035193 | Hyperoncotic ultrahigh molecular weight dextran solutions reduce trypsinogen activation, prevent acinar necrosis, and lower mortality in rodent pancreatitis |
| Q71689839 | Increased intrapancreatic trypsinogen activation in ischemia-induced experimental pancreatitis |
| Q77324104 | Influence of zero-balanced hemofiltration on the course of severe experimental pancreatitis in pigs |
| Q78177010 | Interstitial trypsinogen release and its relevance to the transformation of mild into necrotizing pancreatitis in rats |
| Q78162568 | Intestinal microcirculation and gut permeability in acute pancreatitis: early changes and therapeutic implications |
| Q72693612 | Intravenous contrast medium accentuates the severity of acute necrotizing pancreatitis in the rat |
| Q72158019 | Intravenous contrast medium aggravates the impairment of pancreatic microcirculation in necrotizing pancreatitis in the rat |
| Q71667716 | Isovolemic hemodilution with dextran prevents contrast medium induced impairment of pancreatic microcirculation in necrotizing pancreatitis of the rat |
| Q52959143 | Persistent multiple organ microcirculatory disorders in severe acute pancreatitis: experimental findings and clinical implications. |
| Q34882213 | Prediction of the severity of acute pancreatitis on admission by urinary trypsinogen activation peptide: a meta-analysis |
| Q74099707 | Technetium-99m-labeled white blood cells: a new method to define the local and systemic role of leukocytes in acute experimental pancreatitis |
| Q74099719 | The relative safety of MRI contrast agent in acute necrotizing pancreatitis |
| Q52538844 | Therapy for microcirculatory disorders in severe acute pancreatitis: comparison of delayed therapy with ICAM-1 antibodies and a specific endothelin A receptor antagonist. |
| Q52536333 | Therapy for microcirculatory disorders in severe acute pancreatitis: effectiveness of platelet-activating factor receptor blockade vs. endothelin receptor blockade. |
| Q47153310 | Trypsinogen Activation Peptide Induces HMGB1 Release from Rat Pancreatic Acinar Cells |
| Q34382124 | Trypsinogen activation peptides (TAP) concentrations in the peritoneal fluid of patients with acute pancreatitis and their relation to the presence of histologically confirmed pancreatic necrosis |
| Q77373447 | Trypsinogen activation peptides (TAP) in peritoneal fluid as predictors of late histopathologic injury in necrotizing pancreatitis of the rat |
| Q73634230 | Trypsinogen-2 and trypsinogen activation peptide (TAP) in urine of patients with acute pancreatitis |
| Q73482094 | Urinary trypsinogen activation peptide (TAP) predicts severity in patients with acute pancreatitis |
| Q74637126 | Urinary trypsinogen activation peptide is more accurate than hematocrit in determining severity in patients with acute pancreatitis: a prospective study |
| Q35128138 | Useful Markers for Predicting Severity and Monitoring Progression of Acute Pancreatitis |
Search more.